Author

Yi Si

Hebei Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 4 Approach:experimental assay· 4 Organism:human· 4 Assay:bulk RNA-seq· 2 Assay:metagenomics· 1

Frequent Co-Authors

Mingda Xuan· 4 shared Shuangshuang Han· 4 shared Kunyi LiuiD· 3 shared Weifang Yu· 3 shared Jia WangiD· 2 shared Jiao JiaoiD· 2 shared Ting LiuiD· 2 shared Ting LiuiD· 2 shared

Activity by Year

2025-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

Mingda Xuan

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

YTHDF3 promotes the progression of gastric cancer by activating the Wnt/β-catenin signaling pathway by targeting NEK7

Xiaoran Sun, Yifan Chen, Kunyi Liu, Yi Si, Mingda Xuan, Rui Zhang, Jiao Jiao, Ting Liu, Shuangshuang Han, Jia Wang, Weifang Yu

This study identifies YTHDF3 as a promoter of gastric cancer progression by activating the Wnt/β-catenin pathway through NEK7 regulation.

Journal of Gastroenterology and Hepatology · Jul 30, 2026Peer-reviewedCancer Biology

Integrin beta 4 promotes colorectal cancer progression by upregulating Ezrin and activating the Wnt/β-catenin signaling pathway

Jing Wang, Yi Si, Mingda Xuan, Shuangshuang Han, Kunyi Liu, Jiao Jiao, Xiaoyan Men, Hongfei Li, Jia Wang, Ting Liu, Weifang Yu

This study identifies ITGB4 as a driver of colorectal cancer progression by upregulating Ezrin and activating the Wnt/β-catenin pathway.

International Journal of Oncology · May 19, 2026Peer-reviewedCancer Biology

INHBA promotes the progression of gastric cancer by activating MAPK signaling pathway via targeting ITGA6

Guojian Zhou, Rui Zhang, Lei Nie, Yi Si, Ting Liu, Jing Wang, Shuangshuang Han, Mingda Xuan, Weifang Yu, Jia Wang

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · Jan 1, 2026Peer-reviewedCancer Biology

IGF2BP3 promotes the progression of gastric cancer by activating cGMP-PKG signaling pathway via targeting FBXO32

Yi Si, Bo Tian, Rui Zhang, Mingda Xuan, Kunyi Liu, Jiao Jiao, Shuangshuang Han, Hongfei Li, Yanhong Hu, Hongyan Zhao, Wenjing He, Jia Wang, Ting Liu, Weifang Yu

This study identifies IGF2BP3 as a promoter of gastric cancer progression by upregulating FBXO32 via m6A binding and activating the cGMP-PKG signaling pathway.

World Journal of Gastroenterology · Dec 10, 2025Peer-reviewedCancer Biology